Yuchun Lee - 06 Apr 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
06 Apr 2022
Net transactions value
-$766,804
Form type
4
Filing time
08 Apr 2022, 17:57:26 UTC
Previous filing
06 Apr 2022
Next filing
12 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $163,080 +2,000 +107% $81.54 3,875 06 Apr 2022 Direct
transaction VRTX Common Stock Sale $4,549 -17 -0.44% $267.57 3,858 06 Apr 2022 Direct F1
transaction VRTX Common Stock Sale $81,201 -300 -7.8% $270.67 3,558 06 Apr 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $434,848 -1,600 -45% $271.78 1,958 06 Apr 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $22,646 -83 -4.2% $272.84 1,875 06 Apr 2022 Direct F1, F2, F5
transaction VRTX Common Stock Options Exercise $163,080 +2,000 +107% $81.54 3,875 07 Apr 2022 Direct
transaction VRTX Common Stock Sale $113,741 -417 -11% $272.76 3,458 07 Apr 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale $136,890 -500 -14% $273.78 2,958 07 Apr 2022 Direct F1, F2, F8
transaction VRTX Common Stock Sale $70,467 -256 -8.7% $275.26 2,702 07 Apr 2022 Direct F1, F2, F9
transaction VRTX Common Stock Sale $200,921 -727 -27% $276.37 1,975 07 Apr 2022 Direct F1, F2, F10
transaction VRTX Common Stock Sale $27,702 -100 -5.1% $277.02 1,875 07 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -2,000 -12% $0.000000 14,000 06 Apr 2022 Common Stock 2,000 $81.54 Direct F6
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -2,000 -14% $0.000000 12,000 07 Apr 2022 Common Stock 2,000 $81.54 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $270.67 (range $270.42 to $270.88).
F4 Open market sales reported on this line occurred at a weighted average price of $271.78 (range $271.43 to $272.33).
F5 Open market sales reported on this line occurred at a weighted average price of $272.84 (range $272.56 to $272.97).
F6 Fully vested.
F7 Open market sales reported on this line occurred at a weighted average price of $272.76 (range $272.50 to $273.28).
F8 Open market sales reported on this line occurred at a weighted average price of $273.78 (range $273.52 to $273.98).
F9 Open market sales reported on this line occurred at a weighted average price of $275.26 (range $274.64 to $275.43).
F10 Open market sales reported on this line occurred at a weighted average price of $276.37 (range $275.94 to $276.82).